Naftifine, an effective therapeutic option in limited variety of tinea corporis and cruris: observations from an open label randomized controlled trial

Many clinical trials have been conducted with the purpose of finding better drugs, both in terms of effectiveness and safety in treating dermatophytoses. Luliconazole cream is a preferred treatment option. However, owing to the risk of developing resistance to azoles, allylamines are being tried as potential alternatives. We aimed to evaluate and compare the effectiveness of naftifine 2% cream vs. luliconazole 1% cream in treating dermatophytoses. We found that naftifine can be safely used in the treatment of steroid-modified dermatophytoses and the molecule offers up itself as a new, effective and promising addition to our treatment arsenal for dermatophytoses.